Tango Therapeutics Inc
NASDAQ:TNGX
Balance Sheet
Balance Sheet Decomposition
Tango Therapeutics Inc
Tango Therapeutics Inc
Balance Sheet
Tango Therapeutics Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
143
|
60
|
66
|
0
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
143
|
60
|
66
|
0
|
|
| Short-Term Investments |
0
|
343
|
306
|
271
|
0
|
|
| Total Receivables |
0
|
2
|
2
|
0
|
0
|
|
| Accounts Receivables |
0
|
2
|
2
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
5
|
7
|
10
|
8
|
|
| Total Current Assets |
2
|
492
|
375
|
347
|
266
|
|
| PP&E Net |
0
|
6
|
58
|
53
|
48
|
|
| PP&E Gross |
0
|
6
|
58
|
53
|
0
|
|
| Accumulated Depreciation |
0
|
3
|
4
|
6
|
0
|
|
| Long-Term Investments |
167
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
3
|
0
|
0
|
|
| Total Assets |
168
N/A
|
500
+197%
|
437
-13%
|
403
-8%
|
316
-22%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
3
|
5
|
3
|
2
|
|
| Accrued Liabilities |
0
|
11
|
19
|
17
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
26
|
32
|
26
|
18
|
|
| Total Current Liabilities |
0
|
41
|
56
|
46
|
38
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
6
|
115
|
131
|
104
|
79
|
|
| Total Liabilities |
6
N/A
|
155
+2 490%
|
187
+20%
|
149
-20%
|
117
-21%
|
|
| Equity | ||||||
| Common Stock |
157
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
161
|
270
|
371
|
502
|
|
| Additional Paid In Capital |
5
|
507
|
523
|
624
|
701
|
|
| Other Equity |
0
|
1
|
4
|
0
|
0
|
|
| Total Equity |
162
N/A
|
345
+112%
|
250
-28%
|
253
+1%
|
200
-21%
|
|
| Total Liabilities & Equity |
168
N/A
|
500
+197%
|
437
-13%
|
403
-8%
|
316
-22%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
21
|
88
|
88
|
102
|
108
|
|